Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apollo Medical Inc.

    NASDAQ: AMEH · Real-Time Price · USD
    40.82
    -0.88 (-2.11%)
    At close: Feb 23, 2024, 10:00 PM

    Apollo Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 2.1B 2.59B 2.32B 1.67B 1.54B 1.39B 1.33B 1.3B 1.22B 1.14B 1.05B 955.17M 861.11M 773.91M 755.6M 708.6M 698.13M
    Cost of Revenue
    		 857.65M 857.65M 1.17B 589.43M 882.31M 1.17B 1.11B 1.08B 1.01B 944.69M 863.41M 770.11M 676.26M 596.14M 561.41M 535.76M 535.62M
    Gross Profit
    		 -175.98M -175.98M -137M 111.78M 167.11M 214.96M 217.07M 220.5M 204.8M 199.48M 181.65M 185.06M 184.86M 177.77M 194.19M 172.84M 162.51M
    Operating Income
    		 49.87M 79.94M 55.49M 93.7M 92.31M 84.61M 101.06M 112.07M 100.43M 104.26M 93.93M 97M 102.61M 98.18M 121.81M 106M 97.92M
    Interest Income
    		 13.32M 14.49M 16.77M 15.16M 14.71M 14.21M 10.9M 7.84M 4.94M 1.98M 930K 1.13M 1.27M 1.57M 1.6M 1.93M 2.23M
    Pretax Income
    		 45.14M 60.22M 51.54M 97.65M 102.33M 89.84M 99.37M 102.62M 87.76M 86.61M 53.73M 6.96M 74.78M 77.75M 124.99M 166.67M 195.08M
    Net Income
    		 24.2M 33.95M 39.61M 69.68M 66.76M 60.72M 45.76M 46.89M 45.67M 46.3M 62.67M 73.76M 74.47M 73.86M 70.14M 52.58M 46.97M
    Selling & General & Admin
    		 161.16M 197.12M 191.17M 141.12M 127.37M 112.6M 99.09M 91.07M 86.91M 77.67M 69.83M 70.25M 64.56M 62.08M 54.93M 49.39M 46.75M
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 n/a n/a 1.86M 3.73M 4.92M 6.12M 5.88M 2.69M 4.54M 3.94M 12.66M 14.48M -4.44M -3.75M -14.52M -14.89M 2.28M
    Operating Expenses
    		 161.16M 197.12M 196.07M 150.32M 140.82M 130.34M 116M 108.43M 104.37M 95.21M 87.72M 88.06M 82.25M 79.59M 72.38M 66.84M 64.59M
    Interest Expense
    		 -67.32M -68.53M -55.8M -8.24M 4.25M 16.1M 13.25M 11.89M 10.12M 7.92M 6.4M 4.95M 4.94M 5.39M 5.83M 7.33M 8.15M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 937.11M 937.11M 1.29B 666M 987.18M 1.3B 1.23B 1.18B 1.12B 1.04B 951.12M 858.17M 758.51M 675.74M 633.79M 602.6M 600.21M
    Income Tax Expense
    		 17.74M 21.16M 18.79M 28.92M 35.1M 31.99M 40.96M 48.28M 39.62M 39.52M 26.41M 8.93M 28.5M 28.45M 43.48M 54.35M 61.29M
    Shares Outstanding (Basic)
    		 n/a 47.52M 47.52M 47.52M 47.52M 47.52M 46.55M 46.48M 46.56M 43.33M 44.95M 44.86M 44.68M 44.42M 44.3M 44.17M 42.34M
    Shares Outstanding (Diluted)
    		 n/a 47.52M 47.52M 47.52M 47.52M 47.52M 46.92M 46.78M 46.95M 43.33M 46.15M 46.02M 45.99M 45.9M 46.27M 45.83M 43.57M
    EPS (Basic)
    		 0.55 0.76 0.88 1.47 1.41 1.29 0.97 1.02 1.01 1.04 1.41 1.66 1.68 1.68 1.65 1.34 1.25
    EPS (Diluted)
    		 0.53 0.74 0.86 1.46 1.41 1.29 0.97 1.00 0.98 1.00 1.36 1.60 1.62 1.62 1.59 1.30 1.21
    EBITDA
    		 389.27M 822.69M 823.03M 910.1M 528.33M 128.27M 139.09M 147.85M 134.03M 133.35M 129.18M 132.86M 114.94M 109.21M 123.06M 107.5M 121.24M
    EBIT
    		 -99.59M -99.59M -99.59M 41.79M 76.92M 99.59M 112.62M 114.51M 97.87M 94.54M 60.13M 11.91M 79.73M 83.14M 130.82M 174M 203.23M
    Depreciation & Amortization
    		 420.51M 833.31M 831.37M 827.17M 426.2M 24.39M 27.68M 28.54M 33.61M 29.09M 25.31M 24.87M 19.79M 17.52M 17.45M 17.45M 17.84M

    Add to Watchlist